
Sign up to save your podcasts
Or


On today’s debut interview with Truvian Health, CEO Jay Srinivasan lays out the company’s bold but grounded plan to radically decentralize blood testing. With over $150 million raised and a benchtop instrument already in FDA review, Truvian aims to run 34 lab-quality tests from just eight drops of blood—in under 30 minutes.
“Why does your blood have to t…
By Theral Timpson4.5
3131 ratings
On today’s debut interview with Truvian Health, CEO Jay Srinivasan lays out the company’s bold but grounded plan to radically decentralize blood testing. With over $150 million raised and a benchtop instrument already in FDA review, Truvian aims to run 34 lab-quality tests from just eight drops of blood—in under 30 minutes.
“Why does your blood have to t…

32,058 Listeners

16,078 Listeners

26,344 Listeners

9,583 Listeners

1,094 Listeners

125 Listeners

12,466 Listeners

6,041 Listeners

5,566 Listeners

86 Listeners

34 Listeners

93 Listeners

147 Listeners

16,101 Listeners

97 Listeners